naringenin and Obesity

naringenin has been researched along with Obesity in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (50.00)24.3611
2020's9 (50.00)2.80

Authors

AuthorsStudies
Hwang, BY; Jo, YH; Kim, SB; Lee, JW; Lee, MK; Liu, Q1
Javad Hosseinzadeh-Attar, M; Mahdi Rezayat, S; Mansouri, S; Naeini, F; Namkhah, Z1
Yoshida, H1
Hosseinzadeh-Attar, MJ; Jazayeri-Tehrani, SA; Mansouri, S; Naeini, F; Namkhah, Z; Rezayat, SM; Tutunchi, H; Yaseri, M1
Hosseinzadeh-Attar, MJ; Mansouri, S; Naeini, F; Namkhah, Z; Rezayat, SM; Tutunchi, H; Yaseri, M1
Che, J; Liu, H; Yao, W; Zhao, H1
Li, J; Shi, X; Si, Q; Tan, X; Zhang, S1
Domínguez-Avila, JA; González-Aguilar, GA; López-Almada, G; Mejía-León, ME; Robles-Sánchez, M; Salazar-López, NJ1
Coulter, AA; Coulter, CR; Cusimano, LA; Ghosh, S; Greenway, FL; He, Y; James, SL; Rebello, CJ; Zhang, D1
Banh, T; Belury, MA; Cole, RM; Hsiao, YH; Ke, JY; Straka, SR; Yee, LD1
Coulter, AA; Greenway, FL; Johnson, WD; Lau, FH; Lin, Y; Rebello, CJ; Stephens, JM1
Cao, W; Chen, S; Cheng, N; Liu, X; Zhao, H1
Kurokawa, M; Sugita, C; Tsuhako, R; Yoshida, H1
Alam, MA; Rahman, MM; Reza, HM; Sarker, SD; Subhan, N; Uddin, SJ1
Atsumi, T; Ishida, A; Kurokawa, M; Narumi, K; Sugita, C; Watanabe, H; Watanabe, W; Yoshida, H1
Adams, AC; Assini, JM; Burke, AC; Chhoker, SS; Drangova, M; Huff, MW; Kharitonenkov, A; Mulvihill, EE; Pin, CL; Sawyez, CG; Sutherland, BG; Telford, DE1
Belury, MA; Cole, RM; Cotten, BM; Hamad, EM; Hsiao, YH; Ke, JY; Powell, KA1
Assini, JM; DiMattia, AS; Huff, MW; Khami, M; Koppes, JB; Mulvihill, EE; Sawyez, CG; Sutherland, BG; Whitman, SC1

Reviews

3 review(s) available for naringenin and Obesity

ArticleYear
[Preventive and Ameliorating Effects of Food Factors on Obesity-related Diseases by Regulating Inflammation].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2021, Volume: 141, Issue:10

    Topics: Adipocytes; Adipose Tissue; Aged; Animals; Citrus; Diabetes Mellitus; Female; Flavanones; Flavonoids; Food-Drug Interactions; Humans; Hypoglycemic Agents; Inflammation; Japan; Life Style; Male; Mice; Middle Aged; Obesity; Social Problems

2021
Could Naringenin Participate as a Regulator of Obesity and Satiety?
    Molecules (Basel, Switzerland), 2023, Feb-02, Volume: 28, Issue:3

    Topics: Diabetes Mellitus, Type 2; Flavanones; Humans; Inflammation; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity

2023
Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
    Advances in nutrition (Bethesda, Md.), 2014, Volume: 5, Issue:4

    Topics: Anti-Inflammatory Agents; Antioxidants; Citrus; Flavanones; Humans; Inflammation; Lipid Metabolism; Metabolic Syndrome; Obesity; Oxidative Stress; Phytotherapy; Plant Extracts

2014

Trials

3 trial(s) available for naringenin and Obesity

ArticleYear
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
    International journal of clinical practice, 2021, Volume: 75, Issue:11

    Topics: Dietary Supplements; Double-Blind Method; Flavanones; Humans; Iran; Lipids; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Probability

2021
Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
    Trials, 2021, Nov-13, Volume: 22, Issue:1

    Topics: Dietary Supplements; Double-Blind Method; Flavanones; Humans; Iran; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Randomized Controlled Trials as Topic

2021
Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.
    European journal of gastroenterology & hepatology, 2022, 03-01, Volume: 34, Issue:3

    Topics: Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Flavanones; Heart Disease Risk Factors; Humans; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Risk Factors

2022

Other Studies

12 other study(ies) available for naringenin and Obesity

ArticleYear
Benzylated and prenylated flavonoids from the root barks of Cudrania tricuspidata with pancreatic lipase inhibitory activity.
    Bioorganic & medicinal chemistry letters, 2015, Sep-01, Volume: 25, Issue:17

    Topics: Biological Products; Flavonoids; Lipase; Molecular Structure; Moraceae; Obesity; Pancreas; Plant Extracts

2015
Naringenin Protects against Hypertension by Regulating Lipid Disorder and Oxidative Stress in a Rat Model.
    Kidney & blood pressure research, 2022, Volume: 47, Issue:6

    Topics: Adipokines; Animals; Cholesterol; Flavanones; Hypertension; Lipoproteins, HDL; Obesity; Oxidative Stress; Rats; Superoxide Dismutase; Triglycerides

2022
Naringenin activates beige adipocyte browning in high fat diet-fed C57BL/6 mice by shaping the gut microbiota.
    Food & function, 2022, Oct-03, Volume: 13, Issue:19

    Topics: Adipocytes, Beige; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Bacterial Agents; Diet, High-Fat; Energy Metabolism; Flavanones; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Obesity

2022
Naringenin and β-carotene convert human white adipocytes to a beige phenotype and elevate hormone- stimulated lipolysis.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Adipocytes, White; beta Carotene; Glucose; Hormones; Humans; Insulin Resistance; Lipolysis; Obesity; Phenotype; PPAR gamma; Triglycerides

2023
Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.
    Molecular nutrition & food research, 2017, Volume: 61, Issue:9

    Topics: Adipose Tissue; Adiposity; AMP-Activated Protein Kinases; Animals; Body Weight; Cell Line, Tumor; Cell Survival; Female; Flavanones; Inflammation; Insulin; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Obesity; Ovariectomy

2017
Naringenin Promotes Thermogenic Gene Expression in Human White Adipose Tissue.
    Obesity (Silver Spring, Md.), 2019, Volume: 27, Issue:1

    Topics: Adipose Tissue, White; Animals; Flavanones; Gene Expression; Humans; Male; Mice; Obesity; Thermogenesis

2019
Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice.
    Nutrients, 2019, Feb-06, Volume: 11, Issue:2

    Topics: Animals; Bees; Diet, High-Fat; Disease Models, Animal; Flavanones; Flavonoids; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Pollen; Rutin; Schisandra

2019
Naringenin suppresses neutrophil infiltration into adipose tissue in high-fat diet-induced obese mice.
    Journal of natural medicines, 2020, Volume: 74, Issue:1

    Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Cell Line; Chemokine CCL2; Chemokine CCL7; Chemokine CXCL2; Coculture Techniques; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavanones; Inflammation; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neutrophil Infiltration; Obesity; RAW 264.7 Cells

2020
Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity.
    Biochemical and biophysical research communications, 2014, Nov-07, Volume: 454, Issue:1

    Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Anthracenes; Cell Line; Chemokine CCL2; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavanones; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Obesity; RNA, Messenger; Time Factors

2014
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Endocrinology, 2015, Volume: 156, Issue:6

    Topics: Adipose Tissue; Animals; Fatty Liver; Fibroblast Growth Factors; Flavanones; Glucose Intolerance; Male; Mice; Mice, Knockout; Obesity

2015
Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice.
    Molecular nutrition & food research, 2016, Volume: 60, Issue:2

    Topics: Animals; Body Weight; Citrus; Dietary Supplements; Diglycerides; Energy Intake; Energy Metabolism; Female; Flavanones; Mice, Inbred C57BL; Motor Activity; Muscle, Skeletal; Obesity; Ovariectomy; Postmenopause; Tissue Distribution

2016
Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:4

    Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cholesterol; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Fatty Liver; Flavanones; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptors, LDL; Time Factors; Triglycerides

2010